JAR Cells

The JAR cell line is a human choriocarcinoma cell line derived from trophoblastic cells of placental origin. This cell line is widely utilized in cancer research, particularly in studies related to gestational trophoblastic diseases and placental development. JAR cells exhibit characteristics typical of choriocarcinoma, including high levels of human chorionic gonadotropin (hCG) production, which makes them a valuable model for studying hormone regulation, placental biology, and the mechanisms underlying trophoblastic tumorigenesis. JAR cells are known for their invasive properties and ability to proliferate rapidly, which mirrors the aggressive nature of choriocarcinomas in vivo. These cells are also used to investigate the interaction between trophoblastic cells and the maternal immune system, providing insights into immune evasion mechanisms. Additionally, JAR cells have been employed in studies of drug resistance and chemosensitivity, aiding in the development of therapeutic strategies against trophoblastic cancers. As a cell line derived from human tumors, JAR cells are strictly for in vitro research and are not suitable for any in vivo or therapeutic applications. Reproductive system cancer cell lines, Placenta, Choriocarcinoma, Growth Conditions: Adherent, Biosafety level: BSL 1